Medicare Enrolled
Dr. Michael Dorman, MD
Dermatology · West Bloomfield, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dorman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dorman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dorman
Dr. Michael Dorman is a dermatology specialist in West Bloomfield, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dorman performed 5,377 Medicare services across 3,434 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dorman received a total of $380,577 from 55 pharmaceutical and/or device companies across 1440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dorman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in MI
$380,577 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,377
Medicare services
Top 8% in MI for dermatology
3,434
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~269 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,561 | $5 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
940 | $66 | $165 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
606 | $39 | $120 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
537 | $66 | $188 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
442 | $88 | $235 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
343 | $82 | $205 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
146 | $38 | $96 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
133 | $65 | $204 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $39 | $101 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
82 | $1 | $5 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
80 | $30 | $102 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
75 | $98 | $226 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $101 | $306 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
57 | $85 | $212 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
28 | $53 | $181 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
27 | $129 | $324 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
24 | $160 | $390 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
23 | $45 | $133 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
16 | $137 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
16 | $9 | $40 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
14 | $8 | $15 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
13 | $101 | $270 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
13 | $167 | $376 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 12 | $144 | $343 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
11 | $26 | $164 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
16.5% medium
82.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$380,577
Total received (2018-2024)
Avg $54,368/year across 7 years
Top 1% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
1,440
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$329,417 (86.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$37,257 (9.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,902 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$95,520
2023
$88,695
2022
$57,266
2021
$22,905
2020
$23,183
2019
$32,740
2018
$60,267
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dermavant Sciences, Inc.
$38,979
Janssen Biotech, Inc.
$12,589
UCB, Inc.
$11,985
Galderma Laboratories, L.P.
$11,458
Arcutis Biotherapeutics, Inc.
$8,343
Ortho Dermatologics, a division of Bausch Health US, LLC
$6,904
Amgen Inc.
$2,702
Verrica Pharmaceuticals Inc.
$854
SUN PHARMACEUTICAL INDUSTRIES INC.
$404
ABBVIE INC.
$233
Novartis Pharmaceuticals Corporation
$211
Regeneron Healthcare Solutions, Inc.
$166
GENZYME CORPORATION
$155
Lilly USA, LLC
$153
E.R. Squibb & Sons, L.L.C.
$88
Journey Medical Corporation
$58
PFIZER INC.
$52
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Kyowa Kirin, Inc.
$40
Biofrontera Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Janssen Scientific Affairs, LLC
$25
Organon Llc
$13
Top 3 companies account for 66.5% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$108,034
Dermavant Sciences, Inc.
$64,688
PFIZER INC.
$53,001
Janssen Scientific Affairs, LLC
$37,183
Janssen Biotech, Inc.
$34,810
UCB, Inc.
$19,529
Novartis Pharmaceuticals Corporation
$10,521
Arcutis Biotherapeutics, Inc.
$9,568
Ortho Dermatologics, a division of Bausch Health US, LLC
$7,567
Sun Pharmaceutical Industries Inc.
$7,437
SUN PHARMACEUTICAL INDUSTRIES INC.
$7,072
Amgen Inc.
$2,992
Galderma Research & Development, LLC
$2,678
Biofrontera Inc.
$2,400
EPI Health, LLC
$1,603
Almirall LLC
$1,469
VYNE Pharmaceuticals Inc.
$1,111
Regeneron Healthcare Solutions, Inc.
$898
ABBVIE INC.
$879
Verrica Pharmaceuticals Inc.
$867
AbbVie Inc.
$791
GENZYME CORPORATION
$785
Encore Dermatology Inc.
$739
Lilly USA, LLC
$599
E.R. Squibb & Sons, L.L.C.
$583
AbbVie, Inc.
$501
Journey Medical Corporation
$476
LEO Pharma Inc.
$312
Incyte Corporation
$269
Mayne Pharma Inc.
$155
MAYNE PHARMA COMMERCIAL LLC
$113
SANOFI-AVENTIS U.S. LLC
$113
Johnson & Johnson Health Care Systems Inc.
$107
MAYNE PHARMA INC.
$83
PruGen, Inc. Pharmaceuticals
$76
DERMIRA, INC.
$65
Genentech USA, Inc.
$47
Hologic Sales and Service, LLC
$42
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Sebela Pharmaceuticals Inc.
$40
Kyowa Kirin, Inc.
$40
Glenmark Therapeutics Inc.
$36
DUSA Pharmaceuticals, Inc.
$33
Mylan Pharmaceuticals Inc.
$25
Organon LLC
$25
Smith+Nephew, Inc.
$21
Celgene Corporation
$19
Taro Pharmaceuticals USA, Inc.
$17
Aclaris Therapeutics, Inc.
$15
Mission Pharmacal Company
$14
Organon Llc
$13
Allergan Inc.
$13
STRATA Skin Sciences, Inc.
$12
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 59.3% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMJEVITA · AMZEEQ · ARAZLO · Absorica LD · Acticlate · Aczone · Ameluz · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COLLAGENASE SANTYL · COSENTYX · Cabtreo · Cimzia · CoolSeal Generator · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · HADLIMA · HALOG (Halcinonide Cream · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · LIBTAYO · Mupirocin Cream · NAFTIN · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · PICATO · PRAMOSONE · Poteligeo · QBREXZA · REMICADE · RHOFADE · RINVOQ · SEYSARA · SILIQ · SIMPONI · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Tremfya · USP) 0.1% · VTAMA · Veltin · Verdeso · WYNZORA · Winlevi · XELJANZ · XTRAC · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for dermatology in MI.
Geographic Context
Dermatologists within 10 mi
259
Per 100K population
20.4
County median income
$95,296
Nearest hospital
HENRY FORD HEALTH WEST BLOOMFIELD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dorman is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MI), with speaking/promotional industry engagement in the top 1% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dorman experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Dorman performed 1,561 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dorman receive payments from pharmaceutical companies?
Yes. Dr. Dorman received a total of $380,577 from 55 companies across 1,440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dorman's costs compare to other dermatologists in West Bloomfield?
Dr. Dorman's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dorman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in West Bloomfield
Browse dermatologists in West Bloomfield ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in MI
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in MI
Which MI dermatologists receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
Dermavant Sciences, Inc. Payments to Doctors
See all physicians who received payments from Dermavant Sciences, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology